---
$id: https://graph.org.ai/products/commodity/51292909
$type: Product
source: UNSPSC
code: "51292909"
title: "Lofepramine"
class: "51292900"
classTitle: "Antidepressant dibenzazepines"
family: "51290000"
familyTitle: "Antidepressants"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lofepramine

**UNSPSC Code**: 51292909
**Class**: [Antidepressant dibenzazepines](Antidepressant dibenzazepines.mdx)
**Family**: [Antidepressants](../Antidepressants.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antidepressant agent with the molecular formula C26H27ClN2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OCA4JT7PAW, chemically known as 5,6-dihydro-n-(3-(dimethylamino)propyl)-11h-dibenz(b,e)azepine but generally known as lofepramine, which bears US NIH Compound Identifier 3696. European Medicines Agency schedules Lofepramine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08557MIG. The term LOFEPRAMINE is an International Non-Proprietary Name. World Health Organization schedules lofepramine in its Anatomical Therapeutic Chemical (ATC) Classification. LOFEPRAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lofepramine under HS 29339930 and SITC 51577. As of Q4 2014, LOFEPRAMINE remains the US FDA Preferred Term for this commodity. Lofepramine bears US NLM identifiers UMLS ID C0023961 and NCI Concept Code C87615. SMILES: N1(CCCN(C)C)c2c(CCc3c1cccc3)cccc2.

